MS
Michel Sadelain
Co-founder
About
Director of Columbia Initiative in Cell Engineering & Therapy. Pioneer of CAR-T cell therapy and T-cell engineering. Recipient of 2024 Breakthrough Prize in Life Sciences. Created first effective CAR-T cells in 2002.
Comments
No comments yet. Be the first to share your take.
Frequently asked
Who is Michel Sadelain?
Director of Columbia Initiative in Cell Engineering & Therapy. Pioneer of CAR-T cell therapy and T-cell engineering. Recipient of 2024 Breakthrough Prize in Life Sciences. Created first effective CAR-T cells in 2002.
What is Michel Sadelain's current role?
Michel Sadelain is currently Co-founder.
Where is Michel Sadelain based?
Michel Sadelain is based in New York, United States.
Profile
About Michel Sadelain
Michel Sadelain is Co-founder. Michel is a founder of Juno Therapeutics. Based in New York, United States. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.